Navigation Links
BET Networks' Award-Winning Rap-It-Up HIV/AIDS Campaign Returns to New York City for The Youth Empowerment Tour on November 13-16
Date:11/7/2007

WASHINGTON, Nov. 7 /PRNewswire/ -- BET Networks' national HIV/AIDS public awareness initiative Rap-It-Up returns to New York City to host a series of celebrity health forums throughout New York City and Newark, N.J., to address the social issues, sexual behavior and attitudes impacting today's young adults; as well as the rise of HIV/AIDS in the urban community. Rap-It-Up is partnering with youth empowerment organization Hip Hop 4 Life and local radio station Hot 97 for the weeklong series of HIV/AIDS events taking place on Tuesday, November 13 through Friday, November 16.

The Rap-It-Up four-day tour will visit various local area high schools, including: Harlem's Bread and Roses High School; Newark, N.J.'s East Side High School; the Bronx Community High School; and Brooklyn's Erasmus High School. BET personality Alesha Renee will serve as forum moderator, and forum panelists will include: R&B singer Sammie; HIV/AIDS activist Marvelyn Brown; a local Hot 97 personality; and a local HIV/AIDS educator. There will be a meet & greet for high school students, as well as health materials and giveaways distributed to event attendees following the forums.*

The state of New York ranks #1 of the top 10 states with the most African Americans estimated to be living with AIDS. Today's disturbing statistics have shown that African Americans account for the most AIDS diagnoses, people estimated to be living with AIDS, and HIV-related deaths than any other racial group within the United States. Presently, African-American women account for 67 percent of new AIDS cases among women, and although African-American teens (ages 13-19) represent only 16 percent of U.S. teens, they accounted for 69 percent of newly reported AIDS cases in 2005.

To date, BET's Rap-It-Up campaign has tested more than 11,800 people nationwide for HIV infection; managed more than 1.1 million calls to the Rap- It-Up toll-free hotline; hosted community teen forums for more than 10,000 youth
'/>"/>

SOURCE BET Networks
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. CIDM Collaborates With World Congress to Advance Dialog on Online Provider Networks at WHIT 3.0
2. Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses
3. ImpactRx Announces Expansion and Addition of Physician Information Networks
4. BET Networks Special What U Know Bout That? Rap-It-Up Sex Quiz HIV/AIDS To Premiere On Monday, November 5 At 7:30 P.M. ET/PT
5. Award-winning QUITPLAN(R) Services Billboard Debuts in Rogers
6. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
7. Video: Grin Big With an Award-Winning Smile
8. New St. Lukes Medical Clinic Selects Award-Winning globalcentara Provider(SM) by Houstons Global Healthcare Alliance
9. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
10. Tulane University to receive $14M for international HIV/AIDS program
11. AIDS Action Council Commends Senator Edwards for Endorsing a National HIV/AIDS Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Dr. Stephen Cohen Hired As New CEO, ATLANTA,...r Group,(GMCG) announced today that MELCO Investme...ment fund, has signed on as a key partner with a,s...the investment, GMCG has,also appointed Dr. Stephe...,surgeons, as its new CEO., (Photo: http://www.n...
(Date:7/23/2008)...d and Medicare Rules Highlighted; a Focus on Preve...tions, LANSING, Mich., July 23 /PRNewswire/ -- Th...&PSI), a national leader in clinical risk manageme... care institutions and,providers, today announced ... conference., The conference will take place Sept...
(Date:7/23/2008)... Michigan Takes Top Honors as the #1 Healthiest Ci...PRNewswire-USNewswire/ -- AARP The Magazine, the,d...largest-circulation,magazine with more than 34 mil...st cities to live and retire in with Ann Arbor, MI...go, ND taking the top five rankings.,Featured in t...
(Date:7/23/2008)...a., July 23 /PRNewswire-USNewswire/ -- The HealthC...m ) today announced that Dr. Fran Cogen,MD, direc...am at Children,s,National Medical Center, will pro...om, a site offering connections to a community of ...priate consultation by a dietician, social,worker,...
Breaking Medicine News(10 mins):Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5Health News:Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Network's Teen Diabetes Site 2
...n often disabling condition that affects primarily...ted fatigue // that cannot be overcome with rest a... of the condition is unknown, and there are no dia...hat children who have sedentary behaviors are at i...
...n between the use of two of the most common medica... risk for // bone fractures. Beta-blockers are com...e heart failure, chest pain, and abnormal heart rh...e drugs to prevent a second attack. Diuretics are ...
...Wake Forest University Baptist Medical Center rese...r research in monkeys suggested //that the type of...t heart attack severity. At an annual meeting of...in Washington, D.C. today, Dr. J. Koudy Williams w...
...essive eye disease targeting the light-collecting ...orldwide and can cause // vision loss. Researchers...osa, the addition of docosahexaenoic acid to vitam...enefits, according to a recent study. Researchers ...
Other Medicine News:Health News:Hormone therapy may affect heart attack severity in women 2
(Date:7/22/2008)...ISBANE, Australia, July 22 /PRNewswire-FirstCall/ ... yesterday, the Board of Progen,Pharmaceuticals Li...t it,had discontinued the PI-88 phase 3 study in l...ion to develop its existing portfolio of compounds...itional compounds and,opportunities through Merger...
(Date:7/22/2008)...test awards under Therapeutics Development Initiat...tions to 23; next deadline January 20,2009, NEW ...f its mission to,speed delivery of transformative ... Michael J. Fox Foundation for Parkinson,s Researc... industry research teams. The awards,were granted ...
(Date:7/22/2008)...te-of-the-Art PET Study Confirms Tyrima Exhibits E...operties - - Results Support Initiation of P..., N.C., July 22 /- CeNeRx BioPharma,...ercializing innovative,treatments for diseases of ...to advance its lead candidate Tyrima(TM) into Phas...
(Date:7/22/2008)...UTH SAN FRANCISCO, Calif., July 22 /-...it has completed patient enrollment,in its Phase 1...lity and,ammonia scavenging effects of HPN-100 (fo...nylbutyrate) in patients with urea cycle disorders...ults in the fourth quarter,of this year., (Logo: ...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology 1940 1GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology 1940 2GlycoMark Blood Test Included in Global Diabetes Care Guidelines as Emerging Technology 1940 3Highlights of Economic and Business Growth in the Tampa Bay Region 800 1Highlights of Economic and Business Growth in the Tampa Bay Region 800 2Highlights of Economic and Business Growth in the Tampa Bay Region 800 3Highlights of Economic and Business Growth in the Tampa Bay Region 800 4Poll reveals public awareness of nanotech stuck at low level 1936 1Poll reveals public awareness of nanotech stuck at low level 1936 2Poll reveals public awareness of nanotech stuck at low level 1936 3Pelosi 3A Mr President Drop the Partisan Rhetoric Put Down the Veto Pen 1933 1
... - Dynogen,Pharmaceuticals, Inc. reported positive...controlled Phase 1b trial of DDP733 for,gastroesop...ed to,demonstrate proof-of-concept for DDP733 as a...dose of DDP733 achieved,statistical significance o...n the number of reflux events and was safe and wel...
... 2007 - Gilead,Sciences, Inc. (Nasdaq:GILD) today ...al evaluating the company,s once-daily,anti-HIV dr...vir,DF) 300 mg as a potential treatment for chroni...ry efficacy endpoint. The study shows,that Viread ...ral,drug Hepsera(R) (adefovir dipivoxil) among pat...
Other Medicine Technology:Dynogen Reports Positive Results in Phase 1B GERD Study 2Dynogen Reports Positive Results in Phase 1B GERD Study 3Dynogen Reports Positive Results in Phase 1B GERD Study 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 2Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 3Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 4Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 5Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 6Phase III Study Evaluating Gilead's Viread for the Treatment of,Chronic Hepatitis B Virus Meets Primary Endpoint 7
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
...P Laboratories is a national reference laboratory ...search and development. ARUP offers an extensive t...s in clinical and anatomic pathology. Owned by the...clude more than half of the nation's university te...
Medicine Products: